Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | February 1, 2019 |
| Target | Arvelle Therapeutics |
| Sector | Life Science |
| Investor(s) |
Andera Partners
Eight Roads |
| Deal Type | Venture |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| Deal Context for Investor | # |
|---|---|
| Overall | 71 of 123 |
| Sector: Life Science | 19 of 27 |
| Type: Venture | 20 of 28 |
| Country: Switzerland | 2 of 2 |
| Year: 2019 | 3 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-01 |
CertiNergy & Solutions
75675, France CertiNergy & Solutions brings together expertise in design, implementation and financing of energy efficiency projects. It relies particular on the CEE mechanism to propose efficient projects at a lower cost and is also committed to energy savings within the framework of Energy Performance Contracts.. CertiNergy & Solutions was founded in 2008 and is based in Paris, France. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-11 |
Grey Wolf Therapeutics
Abingdon, United Kingdom Grey Wolf Therapeutics is a biotechnology company focused on developing novel immuno-oncology agents. Grey Wolf Therapeutics was founded in 2017 and is based in Abingdon, United Kingdom. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| Deal Context for Investor | # |
|---|---|
| Overall | 207 of 293 |
| Sector: Life Science | 55 of 73 |
| Type: Venture | 184 of 266 |
| Country: Switzerland | 1 of 1 |
| Year: 2019 | 6 of 21 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-01-31 |
Ashish Life Science
Mumbai, India Ashish Life Science is an export-focussed generic veterinary pharmaceuticals company. Ashish Life Science was founded in 1975 and is based in Mumbai, Maharashtra. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-02-26 |
TreeENT
Hangzhou, China TreeENT is an otolaryngology specialist chain covering areas such as suppurative otitis media, allergic rhinitis, chronic sinusitis and thyroid cancer. It provides users with Danish ear hearing detection, nasal endoscopy video examination and nasopharyngoscopy, specialists test report interpretation and other services; and can use WeChat appointment appointment time, appointment hospital experts. TreeENT was founded in 2016 and is based in Hangzhou, China. |
Buy | - |
